Pharmafile Logo
Pharmafocus logo
Advanced Search
novartis_headquarters

Novartis gains first-line approval for Zykadia in lung cancer

June 29, 2017
Research and Development EMA, European Commission, NSCLC, Novartis

The European Commission has followed the EMA’s CHMP positive opinion by approving Novartis’ Zykadia for first-line treatment of patients with …

News
shutterstock_212035546

Investigational antibody boosts chemotherapy’s cancer-killing potential

June 29, 2017
Research and Development CFH, Cancer, oncology, rituximab

A proof-of-concept study conducted at the Duke Cancer Institute (DCI) in North Carolina has shown that an investigational antibody has …

News
brainss

Enzyme able to untangle protein aggregates associated with Alzheimer’s

June 29, 2017
Research and Development Alzheimer's, Parkinson's

There are currently no effective treatments for neurodegenerative disorders, such as Alzheimer’s and Parkinson’s disease. This is presently a pressing …

News
tablets-1796506_960_720

Researchers in world-first study on antibiotic use for sepsis

June 28, 2017
Research and Development NHS, antibiotic, sepsis

The University of Warwick, alongside the University of Manchester, are launching a world-first study aimed at determining the length of …

News

Regenacy names new President and CEO

June 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Regenacy, appointment

Simon S Jones has been revealed as the new President and Chief Executive Officer of Regenacy Pharmaceuticals, a biopharma company …

Appointment
rosemarie_finley_photo

Myeloma UK’s new CEO begins her role

June 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Myeloma UK

Myeloma UK, the only organisation in the UK dealing exclusively with myeloma, will have a new CEO in place from …

Appointment

FT Global Pharmaceutical and Biotechnology Conference

June 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

News
Press release

Lonza cleared to acquire Capsugel in $5.5 billion deal

June 28, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Capsugel, Lonza, acquisition

Swiss pharmaceutical manufacturer Lonza has announced that it has been cleared to proceed with its $5.5 billion acquisition of New …

News

Gold rods used to ‘break cancer’s legs’

June 28, 2017
Research and Development Cancer, Georgia Tech, nanorods

A study emerging from Georgia Tech has found a new way of stopping metastasising cancer’s spread through the body. The …

News
hack

MSD struck in second global cyber attack

June 28, 2017
Medical Communications, Research and Development Cyber attack, MSD

Following the recent and heavily-publicised ransomware attack which hit the NHS in the UK and almost 100 other countries, the …

News
microneedle-patch4004

Revolutionary patch could offer alternative to flu injections

June 28, 2017
Research and Development flu, flu vaccine, patch delivery

A patch developed by a team at the Georgia Institute of Technology alongside Emory University has found that it is …

News
fdaoutsideweb

FDA weighs in to improve generic competition

June 27, 2017
Medical Communications, Sales and Marketing FDA, generic drugs, pricing debate

Since Scott Gottlieb was appointed Commissioner, the FDA has been on a marked push to tackle two areas: drug pricing …

News

Novo Nordisk’s diabetes drug recommended for expanded indication in Europe

June 27, 2017
Research and Development, Sales and Marketing CHMP, EMA, EU, Novo Nordisk, Victoza

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has given its recommendation to expand the indication of Novo …

News
sanofi_regeneron

New potential blockbuster RA treatment enters European market

June 27, 2017
Sales and Marketing AbbVie, Humria, Kevzara, Regeneron, Sanofi

The world’s biggest selling drug, AbbVie’s Humira with $16 billion in sales last year, has a new rival in the …

News
kress

Biogen appoint new Head of Global Therapeutic Operations

June 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Jean-Paul Kress

Biogen announced that Jean-Paul Kress has been appointed to the position of Executive Vice President and President, International, and Head …

Appointment
novartis_side_building

UK launch of two Novartis biosimilars could cut NHS costs

June 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Erelzi, Novartis, Rixathon, Sandoz, biosimilar, etanercept, rituximab

Sandoz, a division of Swiss pharma giant Novartis, has revealed that two of its biosimilars – Rixathon (biosimilar rituximab) and …

News
filing_cabinet

Number of patients at risk from NHS mail mistake revealed

June 27, 2017
Manufacturing and Production, Medical Communications Department of Health, Jeremy Hunt, NHS, NHS England

According to the patient records that have been examined so far, at least 1,700 may have been put at risk …

News
thumbs_up

Duchenne drug made available to UK patients early

June 27, 2017
Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, Raxone

UK patients will be given access to Santhera Pharmaceutical’s Duchene Muscular Dystrophy (DMD) drug, Raxone (idebenone), through the Early Access …

News
pharmafocus_julyaugust_cover

The July/August 2017 issue of Pharmafocus is now live!

June 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus

The July/August edition of Pharmafocus is now available – click here to read online.

News
pills-384846_960_720

Therapy able to block both opioid high and withdrawal

June 26, 2017
Manufacturing and Production, Research and Development Camurus, buprenorphine

A study into an injectable form of buprenorphine treatment for opioid abuse has found that the formulation is able to …

News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026